| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 10/06/2004 | EP1463756A2 Secreted proteins |
| 10/06/2004 | EP1463755A2 Recombinant polypeptides |
| 10/06/2004 | EP1463754A2 Cystine-knot fold protein |
| 10/06/2004 | EP1463751A2 Albumin fusion proteins |
| 10/06/2004 | EP1463747A2 Novel antibodies that bind to antigenic polypeptides,nucleic acids encodings the antigens, and methodes of use |
| 10/06/2004 | EP1463527A2 The use of gammaglobulin for the treatment of immune-mediated diseases |
| 10/06/2004 | EP1463512A2 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
| 10/06/2004 | EP1463479A2 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 10/06/2004 | EP1073464B1 Monoclonal antibodies with reduced immunogenicity |
| 10/06/2004 | EP1071955B1 Improved immunodiagnostic assays using reducing agents |
| 10/06/2004 | EP0996713B1 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
| 10/06/2004 | EP0862643B1 Accessory functions for use in recombinant aav virion production |
| 10/06/2004 | EP0828842B1 Novel fusion protein recovery and purification methods |
| 10/06/2004 | EP0706563B1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 10/06/2004 | EP0573611B9 Improved epitode displaying phage |
| 10/06/2004 | CN1535314A Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
| 10/06/2004 | CN1535283A Process for preparation of polypeptides of interest from fusion polypeptides |
| 10/06/2004 | CN1535282A Ganalioside-associated recombinant antibodies and use thereof in diagnosis and treatment of tumours |
| 10/06/2004 | CN1535279A Process for producing dipeptide L-amino acid amide hydrolase to be used therein and process for producing L-amino acid amide hydrolase |
| 10/06/2004 | CN1534098A technology of preparing polypeptide from soyabean waste dreg |
| 10/06/2004 | CN1534043A Ubiquition type molecule of human bone marrow substrate cell source and its coding sequence and use |
| 10/06/2004 | CN1169966C Isolated, tyrosinase derived peptides and uses thereof |
| 10/06/2004 | CN1169961C Gene Conversion as a tool for the construction of rcombinant industrial filamentous fungi |
| 10/06/2004 | CN1169959C Polypeptide variants with raised heparin-binding capacity |
| 10/06/2004 | CN1169952C Heavy chain and light chain variable region gene of anti-CD 20 monoclonal antibody and its application |
| 10/06/2004 | CN1169837C Double specific monoclonal anti-body, its preparing method and thromobolysin made therefrom |
| 10/06/2004 | CN1169833C Human Protein with cancer inhibiting function and its coding sequence |
| 10/06/2004 | CN1169832C Identification and function research of gene p28-II |
| 10/06/2004 | CN1169831C Human protein with cancer call growth suppressing function and its coding sequence |
| 10/05/2004 | US6800749 G-protein coupled receptor |
| 10/05/2004 | US6800740 Variants of native growth hormones having non naturally occurring amino acid sequences or covalent modifications |
| 10/05/2004 | US6800737 Amino acid sequences; anticaner agents, monitoring, diagnosis |
| 10/05/2004 | US6800735 Interferon-beta fusion proteins and uses |
| 10/05/2004 | US6800734 Membrane proteins, such as kinase, permease, mannosyltransferase and endoflagellin used to induce a protective immune response in animals; vaccines |
| 10/05/2004 | US6800733 Genetically adjusted fluorescent protein for use as detection tool genetic engineering |
| 10/05/2004 | US6800732 Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same |
| 10/05/2004 | US6800729 Human G-Protein chemokine receptor HDGNR10 (CCR5 receptor) |
| 10/05/2004 | US6800609 Isolated peptide of the horny layer and user thereof |
| 10/05/2004 | US6800604 Polypeptides that inhibit human serum-induced cleavage of hepatocyte growth factor |
| 10/05/2004 | US6800472 Contacting a mammalian cell culture expressing a lysosomal hydrolase with a mutagenic agent; culturing culture in presence of pseudomonas exotoxin a to select for cell resistant to the pseudomonas, isolating lysosomal hydrolase |
| 10/05/2004 | US6800469 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 10/05/2004 | US6800467 Useful as flavor improving agents for food products (soups, sauces, seasonings); protein hydrolysis; obtained from aspergillus, escherichia |
| 10/05/2004 | US6800462 Production of recombinant proteins in vivo and use for generating antibodies |
| 10/05/2004 | US6800461 The b-domain of the wild-type factor viii cdna has been deleted and a truncated factor ix intron 1 has been inserted in one or more locations of the factor viii cdna; vector for human gene therapy |
| 10/05/2004 | US6800447 Methods for identifying compounds which bind the active CCR5 chemokine receptor |
| 10/05/2004 | US6800445 Systems for sensitive detection of G-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 10/05/2004 | US6800441 Heparanase specific molecular probes and their use in research and medical applications |
| 10/05/2004 | US6800285 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 10/05/2004 | CA2136239C Leukotriene c4 synthase |
| 10/05/2004 | CA2128833C P53as protein and antibody therefor |
| 09/30/2004 | WO2004083427A2 Ligational encoding of small molecules |
| 09/30/2004 | WO2004083425A1 Remedy for periodontal disease |
| 09/30/2004 | WO2004083394A2 Human g protein-coupled receptors and modulators thereof for the treatment of inflammatory disorders |
| 09/30/2004 | WO2004082640A2 Human serum albumin conjugates with therapeutic compounds |
| 09/30/2004 | WO2004082629A2 Novel cyclosporins |
| 09/30/2004 | WO2004056850A3 Mutant proteins showing increased secretion |
| 09/30/2004 | WO2004052275A3 Methods of producing lignin peroxidase and its use in skin and hair lightening |
| 09/30/2004 | WO2004037982A3 High expression locus vector based on ferritin heavy chain gene locus |
| 09/30/2004 | WO2003080105A9 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 09/30/2004 | WO2003072740A3 Novel type-1 cytokine receptor glm-r |
| 09/30/2004 | WO2003062447A3 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 09/30/2004 | WO2003049703A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 09/30/2004 | WO2003048328A9 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen |
| 09/30/2004 | US20040194165 Expression vector coding insecticidal protein for use in the transformation and generation of moth resistant leafy plants |
| 09/30/2004 | US20040194157 Animal with surgically modified gastrointestinal tract and method for study of weight reduction |
| 09/30/2004 | US20040192903 Comprises chromosomal regoin which codes pathogenicity islands (PAIs) for use in developing antibodies to detect and prevent bacterial infection; bactericides |
| 09/30/2004 | US20040192899 B-7 domain-specific antibodies |
| 09/30/2004 | US20040192898 Anti-abeta antibodies |
| 09/30/2004 | US20040192895 Extracting plant protein from defatted jojoba meal comprising forming aqueous dispersion with defatted jojoba meal, filtering, drying and recovering plant protein permeate; cosmetics nutraceutical |
| 09/30/2004 | US20040192892 Isolated mammalian membrane protein genes; related reagents |
| 09/30/2004 | US20040192589 Production of high molecular mass lectins |
| 09/30/2004 | US20040191884 Photoprotein derived from okinawan squid and gene encoding the photoprotein |
| 09/30/2004 | US20040191865 Using transgenic cells for propagation of heterologous proteins; bioreactors |
| 09/30/2004 | US20040191864 Methods for producing biological substances in enzyme-deficient mutants of Aspergillus |
| 09/30/2004 | US20040191863 Mutations affecting plasmid copy number |
| 09/30/2004 | US20040191861 Preparing transgenic cells and inducing expression of heterologous sequences; tissue engineering and in vitro translation |
| 09/30/2004 | US20040191859 Fluorescent virus probes for identification of bacteria |
| 09/30/2004 | US20040191858 Preparation method of insect cell extract solution for cell-free protein synthesis, the insect cell extract solution and cell-free synthesis method of protein using the insect cell extract solution |
| 09/30/2004 | US20040191857 Process for the preparation of angiotensis converting enzyme (ACE) inhibitors and its use |
| 09/30/2004 | US20040191856 Using batch processing comprising biomolecules fixed to solid support and air pressure/zones to reduce sample loss in chemical process; microfluidics and enzyme reactions |
| 09/30/2004 | US20040191847 Kit for diagnosing gaucher disease in humans and animals |
| 09/30/2004 | US20040191840 Using immunoglobulins to inactivate viricidal and antitumor activities of huma n type interferon for preventing autoimmunity and graft rejection; immunosuppressants |
| 09/30/2004 | US20040191829 Comprises peptide associated with sugar transport protein for identifying modulators for treatment and prevention of cell proliferative disorder |
| 09/30/2004 | US20040191791 Comprises nucleotide sequences coding sodium voltage gated channels for identifying modulators for treatment of epilepsy; diagnosis of seizure disorders |
| 09/30/2004 | US20040191335 Filtering aqueous dispersion of defatted meal and hydrolyzing with protease enzymes; producing high molecular weight retentate fraction |
| 09/30/2004 | US20040191285 Unhydrolyzed jojoba protein products having high simmondsin concentration and methods of producing the same |
| 09/30/2004 | US20040191259 Nucleotide sequences coding immunoglobin for use in detection and prevention of hepatitis b viral infections; genetic vaccines |
| 09/30/2004 | US20040191236 Administering antigen associated with disease, a dendritic cell binding agent specific for the antigen, and an autologous dendritic cell; immunotherapy |
| 09/30/2004 | US20040188316 Oral administering; blister card; dosage cycles;mixture of calcium and vitamin d |
| 09/30/2004 | US20040187220 Pretanning leather by soaking and dehairing of dry salted animal skins using an alkaline protease isolated from Conidiobolus coronatus culture, applying a paste with sodium sulphide |
| 09/30/2004 | DE10311248A1 Humaner monoklonaler Antikörper Human monoclonal antibodies |
| 09/30/2004 | CA2518265A1 Novel cyclosporins |
| 09/29/2004 | EP1462457A1 Cytotoxic protein and utilization thereof |
| 09/29/2004 | EP1462113A1 CELL GROWTH INHIBITOR CONTAINING ANTI-PepT ANTIBODY |
| 09/29/2004 | EP1462108A1 Interferon g (g) production promoter |
| 09/29/2004 | EP1461446A2 Lipid-associated molecules |
| 09/29/2004 | EP1461445A2 Glycoprotein remodeling using endoglycanases |
| 09/29/2004 | EP1461444A2 Glycopeptide remodeling using amidases |
| 09/29/2004 | EP1461443A2 Carbohydrate-associated proteins |
| 09/29/2004 | EP1461442A2 TRANSGENIC ANIMALS BEARING HUMAN Ig Lambda LIGHT CHAIN GENES |